110
Participants
Start Date
January 1, 2025
Primary Completion Date
August 18, 2025
Study Completion Date
August 18, 2025
Baritinib
Participants will receive additional baritinib administration with 4-mg dosage once daily (QD) for consecutive 14 days after randomization (adjusted dosage of 2-mg QD for participants with eGFR between 30-60 mL/min/1.73m\^2).
First Affiliated Hospital of Gannan Medical University, Ganzhou
Ganzhou People's Hospital, Ganzhou
First Affiliated Hospital of Fujian Medical University, Fuzhou
The Southwest Hospital of Army Medical University, Chongqing
Liaocheng People's Hospital, Liaocheng Brain Hospital, Liaocheng
Tianjin Huanhu Hospital, Tianjin
Fujian Medical University
OTHER
Tianjin Medical University General Hospital
OTHER
De-zhi Kang
OTHER